INTERCOM – Communication between immune cells via release of RNA-carrying vesicles: Lessons from viruses – FP7 ME-had – European Network on Microvesicles and Exosomes in Health and Disease – COST
ME-HaD is a Cooperation in Science and Technology (COST) Action headed up by Trinity College Dublin, Ireland. The Consortium's founding Chair is Professor Lorraine O'Driscoll, a specialist in the role of EVs in cancer, while Professor Marca Wauben, a specialist on immune modulation and inter-organism communication via EVs and technology development is Vice-Chair. ME-HaD involves a large number of European research groups that are working on EVs and fosters a multidisciplinary and inter-sectoral approach to enhancing both basic understanding and translational potential of EVs. To do this, ME-HaD brings together academic, clinical and industry expertise from COST and non-COST countries. It has also developed a forum for the free exchange of concepts in EV research. ME-HaD works closely together with the International Society for Extracellular Vesicles (ISEV), which provides essential training and research opportunities for those involved in EV research.
Document Type: Research Article
Publication date: May 1, 2017
Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.
- Subscribe to this Title
- Terms & Conditions
- Disseminating research in Impact
- Information about Impact
- Ingenta Connect is not responsible for the content or availability of external websites